Delving Into Participation Trends of Scleroderma Clinical Trials

Starting soon

Conditions studied: Scleroderma

In brief

Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics. The study will analyze data from diverse demographic viewpoints to uncover recurring trends that could provide valuable insights for future patients with scleroderma.

Key facts

Study ID

NCT06264492

Run by

Power Life Sciences Inc.

People needed

500

Starts

2025-03-01

Expected to finish

2027-03-01

Last updated by the study team

2024-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has been diagnosed with scleroderma
• Patient has self-identified as planning to enroll in an observational clinical trial
• Patient is a minimum of 18 years or older

You may not qualify if…

• Patient is pregnant
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.